Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jadran - galenski laboratorij (JGL) is a prominent international pharmaceutical company based in Croatia, specializing in the development and production of value-added generic medicines and over-the-counter (OTC) healthcare products. The company is a global leader in the application of seawater for respiratory health, notably through its flagship brand Aqua Maris, and maintains a strong focus on sterile production technologies for ophthalmology and otorhinolaryngology. JGL's portfolio includes a wide range of nasal sprays, eye drops, and dermatological products, many of which utilize advanced preservative-free delivery systems. In addition to its own brands, JGL provides comprehensive contract development and manufacturing (CDMO) services, leveraging its state-of-the-art JGL Pharma Valley production complex. The company operates across more than 60 international markets, with a significant presence in the CIS region and Southeastern Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jadran - galenski laboratorij.